RAB7A and ischemic stroke: Future studies using endothelial-specific ablation of IL-1R1/TNF receptors combined with endothelial-targeted Rab7a knockdown/rescue during the inflammatory challenge will provide clearer insights into the mechanisms by which these pro-inflammatory cytokines act to degrade BBB structure and function after ischemic stroke and guide therapeutic interventions.